Prostate cryoablation: A mini review-Reference-Cited by-同舟云学术

Prostate cryoablation: A mini review

Published:2023-12-01 Issue:4 Volume:3 Page:253-256
ISSN:2719-8073
Container-title:Frigid Zone Medicine
language:en
Short-container-title:

Author:

Zheng Xia¹²,Chen Lihui¹³,Lai Kaiting¹²,Li Zhiyong¹²

Affiliation:

1. 1 State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center , Guangzhou , China

2. 2 Department of Urology, Sun Yat-sen University Cancer Center , Guangzhou , China

3. 3 Department of Head and NeckSurgery, Sun Yat-sen University Cancer Center , Guangzhou , China

Abstract

Abstract In recent years, cryotherapy has gained increasing acceptance as a treatment for prostate cancer, offering complementary therapeutic benefits when combined with radical surgery and radiotherapy. Despite the potential for surgical complications, it stands as a safe and viable therapeutic modality. Cryotherapy provides an efficient approach for elderly patients, especially those with compromised physical conditions and individuals experiencing recurrence after initial treatment. It has shown promise in extending survival periods and improving the overall quality of life for these patients. This article aims to comprehensively examine the developmental trajectory, surgical techniques, indications, therapeutic outcomes, and potential complications associated within prostate cancer treatment.

Publisher

Walter de Gruyter GmbH

Link

https://www.sciendo.com/pdf/10.2478/fzm-2023-0032

Reference20 articles.

1. Feng R M, Zong Y N, Cao S M, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun (Lond), 2019; 39(1): 22.

2. Zhou Z G, Qin J, Song C L, et al. circROBO1 promotes prostate cancer growth and enzalutamide resistance via accelerating glycolysis. J Cancer, 2023; 14(13): 2574–2584.

3. Liu X, Yu C, Bi Y, et al. Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China. Public Health, 2019; 172: 70–80.

4. Kongnyuy M, Halpern D M, Kosinski K E, et al. Cryosurgery, an alternative treatment option for organ-confined prostate cancer: Current beliefs and practice patterns of urologists. Int Urol Nephrol, 2017; 49(1): 43–48.

5. Onik G M, Cohen J K, Reyes G D, et al. Transrectal ultrasound guided percutaneous radical cryosurgical ablation of the prostate. Cancer, 1993; 72(4): 1291–1299.